A new trial will test whether workplace-based exercise can ease the transition back to work for women recovering from breast cancer treatment. An initial 12-week study...
Women aged 25 to 49 in England will be invited for cervical screening every five years instead of three, if they test negative for human papillomavirus...
A menopause drug commonly used to relieve symptoms such as hot flushes may also help slow the growth of breast cancer cells in postmenopausal women, according...
A self-collection device for cervical cancer screening has shown equivalent effectiveness to traditional clinic-based testing, according to new research that could help address screening gaps affecting...
A groundbreaking, cross-industry initiative designed to improve adherence to clinical guidelines in the treatment of early and metastatic breast cancer has been launched by health data company Novellia....
Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancer more common and more deadly. ...
Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, a new trial has found. In women with dense breasts (breasts...
Merck’s immunotherapy drug Keytruda (pembrolizumab) has shown a “statistically significant” survival benefit in platinum-resistant ovarian cancer, potentially offering a new treatment path for patients with few...
British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare...
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated...
